Simplify Health Care ETF
Price through Oct 1 · Flows through Sep 30. Figures use the latest available records, not a live quote. Fund details retrieved Oct 1. Holdings snapshot retrieved Oct 1.
Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 – 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 1M SHOWN · NET −$20M OVER THIS RANGE
Money is leaving — −$20M in net outflows over the past month, about 5.6% of the fund's asset base, while the price has returned +4.3% so far this year. At 0.50% a year it is not the cheapest way in — FDHT has a reported fee of 0.39%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 9.98% | $1149.85 | -0.6% | ||
| 2 | HUMHUMANA | 7.12% | $379.68 | -0.5% | ||
| 3 | ARQTARCUTIS BIOTHERAPEUTICS | 6.55% | $25.29 | -4.3% | ||
| 4 | WRBYWARBY PARKER | 4.99% | $27.49 | -1.0% | ||
| 5 | ABBVABBVIE | 4.82% | $259.93 | -0.6% | ||
| 6 | TMOTHERMO FISHER SCIENTIFIC | 4.67% | $652.51 | -3.3% | ||
| 7 | JNJJOHNSON & JOHNSON | 4.52% | $258.66 | -2.3% | ||
| 8 | UNHUNITEDHEALTH GROUP | 4.31% | $365.20 | -0.5% | ||
| 9 | AVTRAVANTOR | 4.17% | $15.03 | -0.1% | ||
| 10 | PCTPURECYCLE TECHNOLOGIES | 4.20% | $4.29 | -2.7% | ||
| 11 | JAZZJAZZ PHARMACEUTICALS | 3.57% | $233.01 | +0.6% | ||
| 12 | GILDGILEAD SCIENCES | 3.46% | $147.50 | -1.0% | ||
| 13 | DGXQUEST DIAGNOSTICS | 3.31% | $231.09 | -0.8% | ||
| 14 | BNTCBENITEC BIOPHARMA | 2.87% | $9.58 | -4.2% | ||
| 15 | UTHRUNITED THERAPEUTICS | 2.50% | $571.38 | +5.4% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 51| 1 week | -2.0% |
| 1 month | -2.8% |
| 3 months | -3.5% |
| 6 months | +17.5% |
| YTD | +4.3% |
| 1 year | +18.0% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | −$8M |
| 1 month | −$20M |
| 3 months | −$27M |
| YTD | −$27M |
| 1 year | −$27M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 10.0% of the book; the top ten carry 55%. Spread across 53+ names, it behaves like roughly 23 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $30M | $32M |
| UNH UNITEDHEALTH GROUP | $23M | $22M |
| NVO NOVO NORDISK A S | $4M | $14M |
| HUM HUMANA | $8M | $7M |
| AMGN AMGEN | $3M | $4M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat PINK on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.5B | +$286M | -47bp on fee · 119× the assets · +$286M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.2B | +$199M | -47bp on fee · 52× the assets · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.9B | +$497M | -46bp on fee · 94× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$575M | -46bp on fee · 68× the assets · +$575M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -46bp on fee · 53× the assets · +$412M in over the month | Head-to-head |